Article metrics
PDF
Other content recommended for you
- Global equitable access to vaccines, medicines and diagnostics for COVID-19: The role of patents as private governance
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- Pandemic preparedness and response: beyond the Access to COVID-19 Tools Accelerator
- Intellectual property waiver for covid-19 vaccines will advance global health equity
- Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine
- Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom
- Vaccine equity in COVID-19: a meta-narrative review
- A pandemic treaty for equitable global access to medical countermeasures: seven recommendations for sharing intellectual property, know-how and technology
- Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider’s story
- Covid-19: global vaccine production is a mess and shortages are down to more than just hoarding